Kalobios Pharmaceuticals Files for Chapter 11 Bankruptcy - Benzinga

Kalobios Pharmaceuticals Files for Chapter 11 Bankruptcy
Benzinga
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) filed for Chapter 11 bankruptcy protection Tuesday in the U.S. bankruptcy court for the District of Delaware, reports Reuters. The company listed assets and liabilities of $1 million to $10 million,. Also on ...
KaloBios Pharmaceuticals files for bankruptcyReuters
Martin Shkreli's one-time turnaround project, KaloBios, files for bankruptcy ...San Francisco Business Times (blog)
'Pharma bro' company files for bankruptcyWashington Post

all 183 news articles »